ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1014

Enhanced Expression of Rheumatoid Arthritis Related Autoantibodies Following Airborne Endotoxin Exposure in the Setting of Collagen-Induced Arthritis

Ted Mikuls1, Rohit Gaurav1, Geoffrey Thiele1, Bryant England1, Madison Wolfe1, Brianna Shaw1, Kristina Bailey1, Amy Nelson1, Michael Duryee1, Carlos Hunter1, Debra Romberger1, Dana Ascherman2 and Jill Poole1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Pittsburgh, Pittsburgh, PA

Meeting: ACR Convergence 2021

Keywords: Anti-citrullinated Protein Autoantibodies (ACPAs), interstitial lung disease, Mouse Models, RA, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: RA – Animal Models Poster (1014–1021)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: In addition to inflammatory arthritis, collagen-induced arthritis (CIA) recapitulates cardinal features of rheumatoid arthritis (RA) including autoreactive T cells, peptidyl-arginine deiminase expression, and citrullination of synovial antigens. However, CIA is not characterized by robust ACPA expression, a key limitation of this model since ACPA are highly disease specific and play a pathogenic role in RA. Airborne biohazards such as cigarette smoke have been linked with airway generation of citrullinated antigens, ultimately leading to tolerance loss and ACPA production. In prior work, we have shown that combining the inhalant exposure of lipopolysaccharide (LPS; a component of relevant environmental/occupational exposures in RA) with CIA amplifies arthritis and shifts airway inflammation seen with LPS alone towards lung fibrosis. In this study, we examined the effect of repetitive exposure to airborne LPS on airway formation of autoantigens and circulating autoantibodies in CIA.

Methods: DBA/1J male mice were assigned to 4 groups: 1) Sham (saline injection/saline inhalation); 2) CIA alone (CIA injection/saline inhalation); 3) LPS alone (saline injection/LPS 100 ng inhalation); and 4) CIA+LPS (CIA injection/LPS inhalation). Serum and lung tissues were harvested at 5 weeks. ACPA (IgG) and antibody to malondialdehyde-acetaldehyde (IgG anti-MAA [also increased in RA] and anti-MAA-CIT antibody) were measured using ELISA. Lung tissues were examined for citrulline (CIT), MAA adducts, and extracellular matrix proteins (fibronectin, vimentin) using immunohistochemistry. Pearson R2 values were calculated as measures of tissue co-localization.

Results: Serum ACPA, anti-MAA, and anti-MAA-CIT antibodies were strikingly potentiated in CIA+LPS vs. all other groups (p< 0.01; Figure 1). Both CIT- and MAA-modified lung proteins were significantly increased in CIA, LPS, and CIA+LPS vs. Sham, with the highest expression in CIA+LPS (p< 0.01 vs. all other groups) (Figure 2). CIT and MAA co-localization were similarly increased across groups vs. Sham. Lung fibronectin was increased with CIA and LPS and its expression was enhanced in CIA+LPS (Figure 3). Vimentin expression was increased in CIA, LPS, and CIA+LPS vs. Sham, but there were no differences between treated groups. In CIA+LPS lung tissues, CIT co-localized with fibronectin (R2=0.6) but not vimentin (R2=0.12), whereas MAA co-localized with both fibronectin (R2=0.3) and vimentin (R2=0.4).

Conclusion: In the context of arthritis induction, exposure to endotoxin (a ubiquitous airborne biohazard) led to substantial increases in the lung expression of post-translationally modified proteins implicated in RA. Moreover, these combined exposures led to striking increases in serum autoantibodies including a >30-fold increase in ACPA and a 6-fold increase in anti-MAA antibody, yielding an autoantibody profile more closely mimicking human disease. These results emphasize that an underlying predisposition to autoimmunity plus a “second hit” such as an airborne biohazard exposure could be driving tolerance loss and autoimmunity that characterize RA.


Disclosures: T. Mikuls, Gilead Sciences, 2, Horizon, 2, 5, Pfizer Inc, 2, Sanofi, 2, Bristol-Myers Squibb, 2; R. Gaurav, None; G. Thiele, Regeneron, 6; B. England, Boehringer-Ingelheim, 2; M. Wolfe, None; B. Shaw, None; K. Bailey, None; A. Nelson, None; M. Duryee, None; C. Hunter, None; D. Romberger, None; D. Ascherman, None; J. Poole, None.

To cite this abstract in AMA style:

Mikuls T, Gaurav R, Thiele G, England B, Wolfe M, Shaw B, Bailey K, Nelson A, Duryee M, Hunter C, Romberger D, Ascherman D, Poole J. Enhanced Expression of Rheumatoid Arthritis Related Autoantibodies Following Airborne Endotoxin Exposure in the Setting of Collagen-Induced Arthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/enhanced-expression-of-rheumatoid-arthritis-related-autoantibodies-following-airborne-endotoxin-exposure-in-the-setting-of-collagen-induced-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enhanced-expression-of-rheumatoid-arthritis-related-autoantibodies-following-airborne-endotoxin-exposure-in-the-setting-of-collagen-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology